EF Hutton Reiterates Buy on IN8bio, Maintains $8 Price Target
Portfolio Pulse from richadhand@benzinga.com
EF Hutton analyst Tony Butler reiterates a Buy rating on IN8bio (NASDAQ:INAB) and maintains an $8 price target.
June 05, 2023 | 8:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
EF Hutton analyst Tony Butler reiterates a Buy rating on IN8bio and maintains an $8 price target.
The news directly mentions IN8bio (NASDAQ:INAB) and the Buy rating reaffirmation by EF Hutton analyst Tony Butler. This positive rating, along with the maintained $8 price target, indicates a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100